Treatment of COVID-19 patients using plasma therapy: Letter to Editor

Authors

Erfanian, Nafiseh Student Research Committee, Department of Molecular Medicine, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Miri-Moghaddam, Ebrahim Cardiovascular Diseases Research Center, Department of Molecular Medicine, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Abstract:

The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains antibodies against the virus. Following of the plasma therapy have not been reported any serious side effects. Currently, the numbers of these studies are limited, and evaluation of the larger population studies can provide stronger evidence for treating physicians about the effectiveness of this therapeutic approach.

Upgrade to premium to download articles

Already have an account?login

similar resources

Insomnia drug therapy in COVID-19 patients; a Letter to Editor

Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the newly emerging SARS-CoV-2 virus that was first reported in December 2019 and was announced as a pandemic disease on March 11th, according to a World Health Organization (WHO) warning (1). SARS-CoV-2 is mainly transmitted through respiratory droplets and close contact, accordingly, requires treatment in isolation. I...

full text

Role of Oral Cavity in COVID-19 : Letter to Editor

On December 2019, a large number of pneumonia cases with unknown etiology were reported in Wuhan, China. In specimens taken from the throat with a swab, a new virus was founded, which was called COVID-19 by WHO. Due to the small number of studies, we decided to investigate the role of the oral cavity in this disease.

full text

Letter to the Editor: Treatment of Covid-19 with Fisetin flavonoid nanoparticles

A novel coronavirus 2019 (Covid-19) was identified in Wuhan, China causing an outbreak of pneumonia worldwide. The first infection of the coronavirus was associated with a kind of seafood. The patient of the covid-19 pandemic was accompanied by the most common symptoms of fever, lung inflammation, dry cough, and tiredness. Researchers have found that natural flavonoid and antioxidant products s...

full text